2015 (v1)
Publication
Background: A 24–48-week course of interferon-based therapy poorly tolerated in hepatitis C virus (HCV) cirrhosis patients with thrombocytopenia. Aim of the study was to identify patients at low-risk of liverrelated complications over a 12-week course of interferon-based therapy. Methods: We assessed the rate of complications and death during...
Uploaded on: March 27, 2023